Cytotoxic/tumor Suppressor Role of Zinc for the Treatment of Cancer: an Enigma and an Opportunity

Overview

Journal Expert Rev Anticancer Ther

Specialties Oncology
Pharmacology

Date 2011 Dec 14

PMID 22149438

Citations 36

Authors

Leslie C Costello

Renty B Franklin

Affiliations

Soon will be listed here.

Abstract

A major issue relating to many cancers is the absence of effective chemotherapeutic agents; so that most often untreatable morbidity and death are prevalent once the cancer has been detected and has advanced. The search for efficacious anticancer agents is imperative. One potential agent is zinc, which is decreased in the development of some cancers in order to avoid its cytotoxic/tumor suppressor effects on the malignant cells. This provides the basis and opportunity to employ a treatment regimen that restores elevated zinc levels in the malignant cells and elicits the cytotoxic/tumor suppressor effects of zinc. The enigma is that this approach and expectation has not reached fruition. The question is "why?". This article provides a discussion of relevant zinc issues that need to be considered and resolved. Important areas of research are identified as being essential for the successful application of zinc cytotoxicity/tumor suppression actions for the treatment of specific cancers.

Citing Articles

Metal Ion Signaling in Biomedicine.

Rodriguez R, Muller S, Colombeau L, Solier S, Sindikubwabo F, Caneque T Chem Rev. 2025; 125(2):660-744.

PMID: 39746035 PMC: 11758815. DOI: 10.1021/acs.chemrev.4c00577.

Synthesis of Zinc Oxide-Doped Carbon Dots for Treatment of Triple-Negative Breast Cancer.

Wang M, Lan S, Song M, Zhang R, Zhang W, Sun X Int J Nanomedicine. 2025; 19:13949-13971.

PMID: 39742095 PMC: 11687324. DOI: 10.2147/IJN.S494262.

Activated Charcoal-Alginate Platform for Simultaneous Local Delivery of Bioactive Agents: At the Nexus of Antimicrobial and Cytotoxic Activity of Zn Ions.

Osmokrovic A, Jancic I, Zizak Z, Milenkovic M, Obradovic B Gels. 2024; 10(11).

PMID: 39590080 PMC: 11593445. DOI: 10.3390/gels10110724.

Zinc ions activate AKT and promote prostate cancer cell proliferation via disrupting AKT intramolecular interaction.

Wang K, Chen M, Yan S, Han Y, Yuan H, Liu Q Oncogene. 2024; 44(1):8-18.

PMID: 39438763 DOI: 10.1038/s41388-024-03195-x.

A metal-organic nanoframework for efficient colorectal cancer immunotherapy by the cGAS-STING pathway activation and immune checkpoint blockade.

Zhang X, Tian H, Chen Y, Liang B, Nice E, Huang C J Nanobiotechnology. 2024; 22(1):592.

PMID: 39343911 PMC: 11441132. DOI: 10.1186/s12951-024-02836-3.

References

Franklin R, Feng P, Milon B, Desouki M, Singh K, Kajdacsy-Balla A . hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol Cancer. 2005; 4:32. PMC: 1243239. DOI: 10.1186/1476-4598-4-32. View

Liaw K, Lee P, Wu F, Tsai J, Lin-Shiau S . Zinc, copper, and superoxide dismutase in hepatocellular carcinoma. Am J Gastroenterol. 1997; 92(12):2260-3. View

Feng P, Li T, Guan Z, Franklin R, Costello L . Effect of zinc on prostatic tumorigenicity in nude mice. Ann N Y Acad Sci. 2004; 1010:316-20. DOI: 10.1196/annals.1299.056. View

Gurusamy K . Trace element concentration in primary liver cancers--a systematic review. Biol Trace Elem Res. 2007; 118(3):191-206. DOI: 10.1007/s12011-007-0008-x. View

Ding W, Yu H, Lind S . Zinc-binding compounds induce cancer cell death via distinct modes of action. Cancer Lett. 2008; 271(2):251-9. DOI: 10.1016/j.canlet.2008.06.011. View

Ichida T, Matsuda Y, Satoh T, Sugiyama M, Tanaka Y, Ishikawa T . Metallothionein expression and concentrations of copper and zinc are associated with tumor differentiation in hepatocellular carcinoma. Liver. 1998; 17(6):300-6. DOI: 10.1111/j.1600-0676.1997.tb01036.x. View

Franklin R, Ma J, Zou J, Guan Z, Kukoyi B, Feng P . Human ZIP1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells. J Inorg Biochem. 2003; 96(2-3):435-42. PMC: 4465841. DOI: 10.1016/s0162-0134(03)00249-6. View

Costello L, Franklin R . The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer. 2006; 5:17. PMC: 1481516. DOI: 10.1186/1476-4598-5-17. View

Costello L, Franklin R . The genetic/metabolic transformation concept of carcinogenesis. Cancer Metastasis Rev. 2011; 31(1-2):123-30. PMC: 4107361. DOI: 10.1007/s10555-011-9334-8. View

10.

Lightman A, Brandes J, Binur N, DRUGAN A, Zinder O . Use of the serum copper/zinc ratio in the differential diagnosis of ovarian malignancy. Clin Chem. 1986; 32(1 Pt 1):101-3. View

11.

Feng P, Li T, Guan Z, Franklin R, Costello L . The involvement of Bax in zinc-induced mitochondrial apoptogenesis in malignant prostate cells. Mol Cancer. 2008; 7:25. PMC: 2329666. DOI: 10.1186/1476-4598-7-25. View

12.

Yun Y, Li S, Cho Y, Park J, Chun Y . Survivin mediates prostate cell protection by HIF-1alpha against zinc toxicity. Prostate. 2010; 70(11):1179-88. DOI: 10.1002/pros.21152. View

13.

Park S, Park J, Cho Y, Ryu J, Paick J, Chun Y . HIF-1alpha promotes survival of prostate cells at a high zinc environment. Prostate. 2007; 67(14):1514-23. DOI: 10.1002/pros.20641. View

14.

Lemire J, Mailloux R, Appanna V . Zinc toxicity alters mitochondrial metabolism and leads to decreased ATP production in hepatocytes. J Appl Toxicol. 2007; 28(2):175-82. DOI: 10.1002/jat.1263. View

15.

Costello L, Franklin R, Feng P, Tan M, Bagasra O . Zinc and prostate cancer: a critical scientific, medical, and public interest issue (United States). Cancer Causes Control. 2005; 16(8):901-15. DOI: 10.1007/s10552-005-2367-y. View

16.

Al-Ebraheem A, Farquharson M, Ryan E . The evaluation of biologically important trace metals in liver, kidney and breast tissue. Appl Radiat Isot. 2008; 67(3):470-4. DOI: 10.1016/j.apradiso.2008.06.018. View

17.

Mao X, Schimmer A . The toxicology of Clioquinol. Toxicol Lett. 2008; 182(1-3):1-6. DOI: 10.1016/j.toxlet.2008.08.015. View

18.

Doerr T, Prasad A, Marks S, BECK F, Shamsa F, Penny H . Zinc deficiency in head and neck cancer patients. J Am Coll Nutr. 1997; 16(5):418-22. DOI: 10.1080/07315724.1997.10718707. View

19.

Rizk S, SKY-PECK H . Comparison between concentrations of trace elements in normal and neoplastic human breast tissue. Cancer Res. 1984; 44(11):5390-4. View

20.

Santoliquido P, SOUTHWICK H, OLWIN J . Trace metal levels in cancer of the breast. Surg Gynecol Obstet. 1976; 142(1):65-70. View